Insights

Acquisition by Takeda Takeda's acquisition of Maverick Therapeutics for $525M presents an opportunity for cross-selling products or services within the larger Takeda network, leveraging synergies and expanding market reach.

Strategic Partnerships Maverick Therapeutics' collaborations with XVIVO and Inivata open doors for potential joint offerings or bundled services, creating avenues for upselling and diversifying revenue streams.

Innovative Technology Platform Maverick's advanced COBRA platform positions the company as an industry leader, offering a unique selling point to attract potential partners and clients looking for cutting-edge immunotherapy solutions.

Notable Personnel Moves Dr. Degenhardt's transition from Maverick Therapeutics to ImmuneID could present an opportunity to engage with both individuals, tapping into their networks for possible business development and partnership opportunities.

Growing Market Presence Maverick Therapeutics' expansion through its acquisition and partnerships signifies a growing market presence, indicating a potential uptake in demand for innovative T-cell targeted therapies, providing sales opportunities within an expanding market landscape.

Maverick Therapeutics Tech Stack

Maverick Therapeutics uses 8 technology products and services including WP Rocket, WordPress, MySQL, and more. Explore Maverick Therapeutics's tech stack below.

  • WP Rocket
    Caching
  • WordPress
    Content Management System
  • MySQL
    Database
  • Font Awesome
    Font Scripts
  • Typekit
    Font Scripts
  • Google Cloud
    Infrastructure As A Service
  • Modernizr
    Javascript Libraries
  • Yoast SEO
    Search Engines

Media & News

Maverick Therapeutics's Email Address Formats

Maverick Therapeutics uses at least 1 format(s):
Maverick Therapeutics Email FormatsExamplePercentage
FLast@mavericktx.comJDoe@mavericktx.com
50%
FLast@mavericktx.comJDoe@mavericktx.com
50%

Frequently Asked Questions

Where is Maverick Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Maverick Therapeutics's main headquarters is located at 3260 Bayshore Blvd Brisbane, California 94005 US. The company has employees across 6 continents, including North AmericaAsiaEurope.

What is Maverick Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Maverick Therapeutics's main corporate office by phone at +1-650-338-1231. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Maverick Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Maverick Therapeutics's official website is mavericktx.com and has social profiles on LinkedIn.

What is Maverick Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Maverick Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Maverick Therapeutics have currently?

Minus sign iconPlus sign icon
As of April 2022, Maverick Therapeutics has approximately 10K employees across 6 continents, including North AmericaAsiaEurope. Key team members include Owner: D. M.Executive Vice President: P. C.Director: J. V.. Explore Maverick Therapeutics's employee directory with LeadIQ.

What industry does Maverick Therapeutics belong to?

Minus sign iconPlus sign icon
Maverick Therapeutics operates in the Biotechnology Research industry.

What technology does Maverick Therapeutics use?

Minus sign iconPlus sign icon
Maverick Therapeutics's tech stack includes WP RocketWordPressMySQLFont AwesomeTypekitGoogle CloudModernizrYoast SEO.

What is Maverick Therapeutics's email format?

Minus sign iconPlus sign icon
Maverick Therapeutics's email format typically follows the pattern of . Find more Maverick Therapeutics email formats with LeadIQ.

How much funding has Maverick Therapeutics raised to date?

Minus sign iconPlus sign icon
As of April 2022, Maverick Therapeutics has raised $125M in funding. The last funding round occurred on Jan 01, 2017 for $125M.
Maverick Therapeutics

Maverick Therapeutics

Biotechnology ResearchCalifornia, United States10001+ Employees

Maverick Therapeutics is now part of Takeda. Follow us at https://www.linkedin.com/company/takeda-pharmaceuticals/

Maverick Therapeutics is pioneering the next generation of redirected T-cell targeted immunotherapies. Maverick’s highly innovative platform, COBRA™, is the most advanced bispecific T-cell engaging platform in its class, designed to safely target solid tumors with highly specific and potent activity.

Section iconCompany Overview

Headquarters
3260 Bayshore Blvd Brisbane, California 94005 US
Phone number
+1-650-338-1231
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
10001+

Section iconFunding & Financials

  • $125M

    Maverick Therapeutics has raised a total of $125M of funding over 1 rounds. Their latest funding round was raised on Jan 01, 2017 in the amount of $125M.

Section iconFunding & Financials

  • $125M

    Maverick Therapeutics has raised a total of $125M of funding over 1 rounds. Their latest funding round was raised on Jan 01, 2017 in the amount of $125M.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.